HAL-RAR Technique for Treating Hemorrhoids
Safety and Effectiveness of Hemorrhoidal Artery Ligation Using the HAL-RAR Technique for Hemorrhoidal Disease
1 other identifier
interventional
105
0 countries
N/A
Brief Summary
A wide variety of methods has been proposed for treating hemorrhoidal disease with excisional hemorrhoidectomy remaining the gold standard. The aim of this trial is to assess the safety and effectiveness of the HAL-RAR technique in treating hemorrhoidal disease. Arterial ligation was performed by using the highest doppler signal to locate the site of the hemorrhoidal artery in combination with RAR in order to reposition redundant rectal mucosa/submucosa that prolapses to its original anatomical location, leading to resolution of symptoms. This is a retrospective study from January 2010 to November 2019 of patients who underwent HAL-RAR for hemorrhoidal disease. Demographics, degree of disease, length of hospital stay, postoperative pain, complications (urinary retention, dyschezia, bleeding, necrosis of a hemorrhoid, anal discomfort, sensation of fullness) and recurrence were recorded. Patients were followed-up at postoperative day 1 and 8, and at 1, 6 and 12 months. The main outcome of the study was recurrence. Secondary outcomes included postoperative complications, postoperative pain and patient-assessed resolution of symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2010
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedFirst Submitted
Initial submission to the registry
February 25, 2021
CompletedFirst Posted
Study publicly available on registry
March 2, 2021
CompletedMarch 2, 2021
February 1, 2021
9.8 years
February 25, 2021
February 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Recurrence
Recurrence was evaluated after physical examination and defined as a relapse of symptoms such as bleeding or prolapse often daily requiring manual reduction.
Postoperatively at 1 month
Recurrence
Recurrence was evaluated after physical examination and defined as a relapse of symptoms such as bleeding or prolapse often daily requiring manual reduction.
Postoperatively at 6 months
Recurrence
Recurrence was evaluated after physical examination and defined as a relapse of symptoms such as bleeding or prolapse often daily requiring manual reduction.
Postoperatively at 12 months
Secondary Outcomes (11)
Postoperative complications
Postoperative day 1
Postoperative complications
Postoperative day 8
Postoperative complications
Postoperatively at 1 month
Postoperative pain
Postoperative day 1
Postoperative pain
Postoperative day 8
- +6 more secondary outcomes
Study Arms (1)
Patients with hemorrhoidal disease undergoing HAL-RAR
OTHERThis is a single-arm trial, in which all patients with grade II hemorrhoidal disease resistant to conservative treatment, grade III and IV hemorrhoidal disease underwent HAL RAR surgery.
Interventions
All patients underwent hemorrhoidal artery ligation on multiple sites according to pulsations detected by the doppler transducer and mucopexy (RAR) at the sites of prolapse.
One patient with mucosal necrosis of the hemorrhoidal cushion postoperatively underwent hemorrhoidectomy with excision of necrotic tissues.Furthermore, 2 patients who presented with hemorrhoidal thrombosis postoperatively underwent emergency surgery with supplementary excision of the thrombosed hemorrhoid. In addition, 9 patients who experienced recurrence of hemorrhoidal disease after undergoing HAL-RAR surgery, were treated with hemorrhoidectomy according to the Milligan-Morgan procedure.
Eligibility Criteria
You may qualify if:
- Patients with
- grade II hemorrhoidal disease, resistant to conservative treatment
- grade III hemorrhoidal disease,
- grade IV hemorhoidal disease,
- that underwent the HAL-RAR technique.
You may not qualify if:
- pregnancy
- coagulation disorders
- patients with major comorbidities (American Society of Anesthesiologists \[ASA\] ≥3),
- psychiatric conditions preventing collaboration and follow-up
- other concomitant anorectal disease (rectal prolapse, anal fissure, anal stenosis, perianal fistula or abscess, fecal incontinence)
- previous pelvic radiotherapy
- declined consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (7)
Morinaga K, Hasuda K, Ikeda T. A novel therapy for internal hemorrhoids: ligation of the hemorrhoidal artery with a newly devised instrument (Moricorn) in conjunction with a Doppler flowmeter. Am J Gastroenterol. 1995 Apr;90(4):610-3.
PMID: 7717320BACKGROUNDRatto C, Campenni P, Papeo F, Donisi L, Litta F, Parello A. Transanal hemorrhoidal dearterialization (THD) for hemorrhoidal disease: a single-center study on 1000 consecutive cases and a review of the literature. Tech Coloproctol. 2017 Dec;21(12):953-962. doi: 10.1007/s10151-017-1726-5. Epub 2017 Nov 24.
PMID: 29170839BACKGROUNDPopov V, Yonkov A, Arabadzhieva E, Zhivkov E, Bonev S, Bulanov D, Tasev V, Korukov G, Simonova L, Kandilarov N, Taseva A, Dimitrova V. Doppler-guided transanal hemorrhoidal dearterilization versus conventional hemorrhoidectomy for treatment of hemorrhoids - early and long-term postoperative results. BMC Surg. 2019 Jan 10;19(1):4. doi: 10.1186/s12893-019-0469-9.
PMID: 30630463BACKGROUNDAigner F, Gruber H, Conrad F, Eder J, Wedel T, Zelger B, Engelhardt V, Lametschwandtner A, Wienert V, Bohler U, Margreiter R, Fritsch H. Revised morphology and hemodynamics of the anorectal vascular plexus: impact on the course of hemorrhoidal disease. Int J Colorectal Dis. 2009 Jan;24(1):105-13. doi: 10.1007/s00384-008-0572-3. Epub 2008 Sep 3.
PMID: 18766355BACKGROUNDGallo G, Martellucci J, Sturiale A, Clerico G, Milito G, Marino F, Cocorullo G, Giordano P, Mistrangelo M, Trompetto M. Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease. Tech Coloproctol. 2020 Feb;24(2):145-164. doi: 10.1007/s10151-020-02149-1. Epub 2020 Jan 28.
PMID: 31993837BACKGROUNDEmile SH, Elfeki H, Sakr A, Shalaby M. Transanal hemorrhoidal dearterialization (THD) versus stapled hemorrhoidopexy (SH) in treatment of internal hemorrhoids: a systematic review and meta-analysis of randomized clinical trials. Int J Colorectal Dis. 2019 Jan;34(1):1-11. doi: 10.1007/s00384-018-3187-3. Epub 2018 Nov 12.
PMID: 30421308BACKGROUNDKarkalemis K, Chalkias PL, Kasouli A, Chatzaki E, Papanikolaou S, Dedemadi G. Safety and effectiveness of hemorrhoidal artery ligation using the HAL-RAR technique for hemorrhoidal disease. Langenbecks Arch Surg. 2021 Nov;406(7):2489-2495. doi: 10.1007/s00423-021-02190-0. Epub 2021 May 6.
PMID: 33959805DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Georgia Dedemadi, MD, PhD
Amalia Fleming Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, FACS
Study Record Dates
First Submitted
February 25, 2021
First Posted
March 2, 2021
Study Start
January 1, 2010
Primary Completion
November 1, 2019
Study Completion
November 1, 2019
Last Updated
March 2, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share